Shares of Palantir Technologies Inc PLTR rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter results.
Palantir reported second-quarter revenue of $678.13 million, beating the consensus estimate of $652.1 million, according to Benzinga Pro. Palantir reported second-quarter adjusted earnings of 9 cents per share, beating analyst estimates of 8 cents per share.
Palantir Technologies shares surged 9.6% to $26.40 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Lytus Technologies Holdings PTV. Ltd. LYT rose 79.1% to $2.56 in today's pre-market trading after dipping over 12% on Monday.
- Lumen Technologies, Inc. LUMN gained 44.8% to $3.75 in pre-market trading after the company announced it secured $5 billion in new business from companies seeking to quickly secure their fiber capacity.
- CNS Pharmaceuticals, Inc. CNSP gained 28.7% to $0.25 in pre-market trading after tumbling over 22% on Monday.
- AgriFORCE Growing Systems Ltd. AGRI jumped 27% to $0.0725 in pre-market trading after falling more than 5% on Monday.
- Agape ATP Corporation ATPC shares gained 26.6% to $0.1570 in pre-market trading after dipping 18% on Monday.
- Rxsight Inc RXST shares gained 22.7% to $50.00 in pre-market trading after the company posted upbeat second-quarter sales and raised its FY24 revenue forecast.
- Serve Robotics Inc SERV shares rose 15.3% to $15.70 in pre-market trading after falling around 7% on Monday.
- Lucid Group Inc LCID shares gained 13% to $3.39 in pre-market trading after the company reported better-than-expected second-quarter sales results and announced a $1.5 billion public investment fund commitment.
- DDC Enterprise Limited DDC shares rose 10.8% to $0.5159 in pre-market trading following around 13% surge on Monday.
Losers
- SunPower Corporation SPWR shares dipped 24.6% to $0.61 in pre-market trading. SunPower announced a $45 million asset sale to complete Solaria and filed Chapter 11 to maximize asset value.
- Chegg Inc CHGG shares declined 18.7% to $2.38 in pre-market trading following second-quarter results.
- Actinium Pharmaceuticals, Inc. ATNM declined 15.3% to $2.10 in pre-market trading after dipping 60% on Monday. On Monday, the FDA determined that Actinium Pharmaceuticals’ Phase 3 SIERRA trial is not adequate to support a Biologics License Application (BLA) filing for Iomab-B despite its statistically significant primary endpoint.
- ZoomInfo Technologies Inc. ZI shares declined 15.2% to $8.31 in pre-market trading after the company reported worse-than-expected financial results for the second quarter and announced a management transition. The company announced that CFO Cameron Hyzer will step down from his role. Hyzer will remain in an advisory capacity until Oct. 7 to help facilitate a smooth transition. Graham O’Brien has been named interim CFO, effective Sept. 6.
- Helport AI HPAI shares fell 15.2% to $7.15 in pre-market trading after declining 24% on Monday.
- TenX Keane Acquisition TENK fell 14.1% to $31.00 pre-market trading. TenX Keane shares jumped 193% on Monday after shareholders approved the combination with Citius Pharma’s oncology subsidiary.
- Upexi Inc UPXI fell 12.4% to $0.25 in today's pre-market trading.
- Bluejay Diagnostics, Inc. BJDX shares fell 11.8% to $0.4010 in pre-market trading after declining 18% on Monday.
- Trio Petroleum Corp. TPET shares fell 11.2% to $0.2594 in pre-market trading after gaining more than 19% on Monday.
- Sumitomo Mitsui Financial Group, Inc. SMFG fell 10.5% to $10.80 in pre-market trading after declining around 4% on Monday.
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.